相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Molecular Basis of Allele-Specific Efficacy of a Blood-Stage Malaria Vaccine: Vaccine Development Implications
Amed Ouattara et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Analysis of the Conformation and Function of the Plasmodium falciparum Merozoite Proteins MTRAP and PTRAMP
Onyinyechukwu Uchime et al.
EUKARYOTIC CELL (2012)
Humoral Immune Responses to a Single Allele PfAMA1 Vaccine in Healthy Malaria-Naive Adults
Edmond J. Remarque et al.
PLOS ONE (2012)
Defining the Antigenic Diversity of Plasmodium falciparum Apical Membrane Antigen 1 and the Requirements for a Multi-Allele Vaccine against Malaria
Damien R. Drew et al.
PLOS ONE (2012)
Safety and immunogenicity of multi-antigen AMA1-based vaccines formulated with CoVaccine HT™ and Montanide ISA 51 in rhesus macaques
Kwadwo A. Kusi et al.
MALARIA JOURNAL (2011)
First Results of Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Children
Selidji Todagbe Agnandji et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
A Field Trial to Assess a Blood-Stage Malaria Vaccine
Mahamadou A. Thera et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Impact on Malaria Parasite Multiplication Rates in Infected Volunteers of the Protein-in-Adjuvant Vaccine AMA1-C1/Alhydrogel+CPG 7909
Christopher J. A. Duncan et al.
PLOS ONE (2011)
Worldwide Incidence of Malaria in 2009: Estimates, Time Trends, and a Critique of Methods
Richard E. Cibulskis et al.
PLOS MEDICINE (2011)
In Vitro Growth-Inhibitory Activity and Malaria Risk in a Cohort Study in Mali
Peter D. Crompton et al.
INFECTION AND IMMUNITY (2010)
Allelic Diversity and Naturally Acquired Allele-Specific Antibody Responses to Plasmodium falciparum Apical Membrane Antigen 1 in Kenya
Faith H. A. Osier et al.
INFECTION AND IMMUNITY (2010)
Generation of Humoral Immune Responses to Multi-Allele PfAMA1 Vaccines; Effect of Adjuvant and Number of Component Alleles on the Breadth of Response
Kwadwo A. Kusi et al.
PLOS ONE (2010)
Structure of the Plasmodium falciparum Circumsporozoite Protein, a Leading Malaria Vaccine Candidate
Matthew L. Plassmeyer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Phase 1/2a Study of the Malaria Vaccine Candidate Apical Membrane Antigen-1 (AMA-1) Administered in Adjuvant System AS01B or AS02A
Michele D. Spring et al.
PLOS ONE (2009)
Humoral Immune Response to Mixed PfAMA1 Alleles; Multivalent PfAMA1 Vaccines Induce Broad Specificity
Kwadwo A. Kusi et al.
PLOS ONE (2009)
High Antibody Titer against Apical Membrane Antigen-1 Is Required to Protect against Malaria in the Aotus Model
Sheetij Dutta et al.
PLOS ONE (2009)
A randomized controlled phase 2 trial of the blood stage AMA1-C1/Alhydrogel malaria vaccine in children in Mali
Issaka Sagara et al.
VACCINE (2009)
A diversity-covering approach to immunization with Plasmodium falciparum apical membrane antigen 1 induces broader allelic recognition and growth inhibition responses in rabbits
Edmond J. Remarque et al.
INFECTION AND IMMUNITY (2008)
Phase 1 Trial of AMA1-C1/Alhydrogel plus CPG 7909: An Asexual Blood-Stage Vaccine for Plasmodium falciparum Malaria
Gregory E. D. Mullen et al.
PLOS ONE (2008)
Antibody-Mediated Growth Inhibition of Plasmodium falciparum: Relationship to Age and Protection from Parasitemia in Kenyan Children and Adults
Arlene E. Dent et al.
PLOS ONE (2008)
Population structure of the genes encoding the polymorphic Plasmodium falciparum apical membrane antigen 1:: Implications for vaccine design
Junhui Duan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Development and characterization of a standardized ELISA including a reference serum on each plate to detect antibodies induced by experimental malaria vaccines
Kazutoyo Miura et al.
VACCINE (2008)
In immunization with Plasmodium falciparum apical membrane antigen 1, the specificity of antibodies depends on the species immunized
Kazutoyo Miura et al.
INFECTION AND IMMUNITY (2007)
Structural basis of antigenic escape of a malaria vaccine candidate
Sheetij Dutta et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Phase I dose escalation safety and immunogenicity trial of Plasmodium falciparum apical membrane protein (AMA-1) FMP2.1, adjuvanted with AS02A, in malariu-naive adults at the Walter Reed Army Institute of Research
Mark E. Polhemus et al.
VACCINE (2007)
Structure of AMA1 from Plasmodium falciparum reveals a clustering of polymorphisms that surround a conserved hydrophobic pocket
T Bai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Posttranslational modification of recombinant Plasmodium falciparum apical membrane antigen 1:: Impact on functional immune responses to a malaria vaccine candidate
B Giersing et al.
INFECTION AND IMMUNITY (2005)
Crystal structure of the malaria vaccine candidate apical membrane antigen 1
JC Pizarro et al.
SCIENCE (2005)
Antibodies to the conserved C-terminal domain of the Plasmodium falciparum merozoite surface protein 1 and to the merozoite extract and their relationship with in vitro inhibitory antibodies and protection against clinical malaria in a Senegalese village
R Perraut et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Geographical structure of diversity and differences between symptomatic and asymptomatic infections for Plasmodium falciparum vaccine candidate AMA1
A Cortes et al.
INFECTION AND IMMUNITY (2003)
In vitro studies with recombinant Plasmodium falciparum apical membrane antigen 1 (AMA1):: Production and activity of an AMA1 vaccine and generation of a multiallelic response
MC Kennedy et al.
INFECTION AND IMMUNITY (2002)
Proteolytic processing and primary structure of Plasmodium falciparum apical membrane antigen-1
SA Howell et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Apical membrane antigen 1 plays a central role in erythrocyte invasion by Plasmodium species
T Triglia et al.
MOLECULAR MICROBIOLOGY (2000)
分享论文
